Johnson & Johnson to Start Testing its Vaccine on 12-Year-Olds
Johnson & Johnson to Start Testing its Vaccine on 12-Year-Olds

J&J said that it would be expanding its Phase 2a study of its Janssen vaccine to include “a small number” of older children and teens.